logo ecco
Portal

Search

Poster presentations: Microbiology 2021

P674 Definition of a microbial signature as a predictor of anti-TNFα treatment response

P675 Flavonoid-degrading bacteria have central positions in correlation network analysis in patients with Inflammatory Bowel Disease

P676 The small intestinal microbiome in Crohn’s disease is characterised by increased luminal diversity and stable mucosa-associated communities

P677 Fungal abundance is related to inflammatory status in Ulcerative Colitis

P678 Definition of a microbial signature as a predictor of post-surgical recurrence in patients with Crohn's disease

P679 The keystone bacterium Christensenella minuta improves colitis in in vivo preclinical Inflammatory Bowel Disease models

P680 Similar gut bacterial composition between patients with ulcerative colitis and healthy controls in a high prevalence population: a cross-sectional study of the Faroe Islands IBD cohort

P681 Higher in vitro mucin degradation, but no increased paracellular permeability by faecal water from Crohn’s disease patients

P682 Antibiotic resistome profiles of fecal Escherichia coli isolates in association with Crohn’s disease

P683 Patients with newly diagnosed fistulizing perianal Crohn's disease have a distinct microbial signature

P684 Multiplex Gastrointestinal Pathogen Panel Testing is Associated with Higher Rates of Inflammatory Bowel Disease Therapy Escalation in Patients Hospitalised with Flare

P685 Gut microbiota in patients with Inflammatory Bowel Disease during remission

P686 Novel grape-derived prebiotic selectively enhances abundance and metabolic activity of IBD and IBS faecal butyrate producing bacteria in an in vitro model of intestinal fermentation

P687 Development of a panel of microbial markers to distinguish transient from pathological dysbiosis

P688 Association of Akkermansia muciniphila with a healthy gut microbiome

P689 Aeromonas infection and Inflammatory Bowel Disease: a single tertiary center analysis

P690 Changes of intestinal microbiota in patients with inflammatory bowel diseases